抗真菌药物靶标及其抑制剂的研究进展 |
投稿时间:2012-12-14 修订日期:2013-04-08 点此下载全文 |
引用本文:徐波,蒋琰,张万年,盛春泉.抗真菌药物靶标及其抑制剂的研究进展[J].药学实践杂志,2013,31(5):321~325,379 |
摘要点击次数: 1173 |
全文下载次数: 236 |
|
基金项目:国家自然科学基金重点项目(30930107). |
|
中文摘要:目的 综述抗真菌药物靶标及其抑制剂的研究进展。方法 本文结合自身研究工作,分析近5年文献,总结抗真菌药物靶标及其抑制剂的最新进展。结果 β-1,3-葡聚糖合成酶、羊毛甾醇 14α-去甲基化酶、N-肉豆蔻酰基转移酶和分泌型天冬氨酸蛋白酶是目前研究最为集中的抗真菌药靶,其抑制剂显示了良好的新药开发前景。结论 优化现有药物化学结构和发现全新作用机制的先导化合物,对研发新一代抗真菌药物具有重要意义。 |
中文关键词:抗真菌药物靶标 β-1,3-葡聚糖合成酶 羊毛甾醇14α-去甲基化酶 N-肉豆蔻酰基转移酶 分泌型天冬氨酸蛋白酶 |
|
Progress on antifungal drug targets and inhibitors |
|
|
Abstract:Objective To review recent progress of antifungal drug targets and their inhibitors.Methods Literatures in recent five years were analyzed in combination of the authors'own research work and recent developments of antifungal targets and inhibitors were summarized.Results Current research focused on lanosterol 14-demethylase, β-1,3-glucan synthase, N-myristoyltransferase and secreted aspartic protease. The inhibitors of these targets showed promising future for the development of new antifungal drugs.Conclusion Optimizing the chemical structures of current antifungal agents and discover lead compounds with novel mode of action are of great importance to develop new generation of antifungal agents. |
keywords:antifungal drug targets lanosterol 14-demethylase β-1,3-glucan synthase N-myristoyltransferase Secreted aspartic protease |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |
|
|
|